• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Biol Chem . Prefusion Spike Protein Conformational Changes Are Slower in SARS-CoV-2 than in SARS-CoV-1

tetano

Editor, Senior Moderator
J Biol Chem


. 2022 Mar 9;101814.
doi: 10.1016/j.jbc.2022.101814. Online ahead of print.
Prefusion Spike Protein Conformational Changes Are Slower in SARS-CoV-2 than in SARS-CoV-1


Vivek Govind Kumar[SUP] 1 [/SUP], Dylan S Ogden[SUP] 1 [/SUP], Ugochi H Isu[SUP] 1 [/SUP], Adithya Polasa[SUP] 1 [/SUP], James Losey[SUP] 1 [/SUP], Mahmoud Moradi[SUP] 2 [/SUP]



Affiliations

Abstract

Within the last two decades, severe acute respiratory syndrome coronaviruses 1 and 2 (SARS-CoV-1 and SARS-CoV-2) have caused two major outbreaks; yet for reasons not fully understood, the COVID-19 pandemic caused by SARS-CoV-2 has been significantly more widespread than the 2003 SARS epidemic caused by SARS-CoV-1 despite striking similarities between these two viruses. The SARS-CoV-1 and SARS-CoV-2 spike proteins, both of which bind to host cell angiotensin converting enzyme 2 (ACE2), have been implied to be a potential source of their differential transmissibility. However, the mechanistic details of prefusion spike protein binding to ACE2 remain elusive at the molecular level. Here, we performed an extensive set of equilibrium and nonequilibrium microsecond-level all-atom molecular dynamics (MD) simulations of SARS-CoV-1 and -2 prefusion spike proteins to determine their differential dynamic behavior. Our results indicate that the active form of the SARS-CoV-2 spike protein is more stable than that of SARS-CoV-1 and the energy barrier associated with the activation is higher in SARS-CoV-2. These results suggest that not only the receptor binding domain (RBD), but also other domains such as the N-terminal domain (NTD), could play a crucial role in the differential binding behavior of SARS-CoV-1 and -2 spike proteins.
 
Back
Top Bottom